The pituitary hormones LH, 1 thyrotropin, and pro-opiomelanocortin bear unique N-linked oligosaccharides that terminate with the sequence SO 4 -4-GalNAc␤1,4GlcNAc␤1,2Man␣ (1-6).
The pituitary hormones LH, 1 thyrotropin, and pro-opiomelanocortin bear unique N-linked oligosaccharides that terminate with the sequence SO 4 -4-GalNAc␤1,4GlcNAc␤1,2Man␣ (1-6).
The terminal GalNAc-4-SO 4 is recognized by a receptor, the Man/GalNAc-4-SO 4 receptor (7-9), which is located in hepatic endothelial cells and controls the circulatory half-life of LH and other glycoproteins bearing this structure (10, 11) . A short circulatory half-life in conjunction with the regulated release from storage granules in the gonadotroph produces the episodic rise and fall seen in circulating LH levels (12, 13) . This is essential for efficient activation of the LH receptor in the ovary and testis due to the down-regulation and internalization of the activated receptor by ␤-arrestin (14) . Sequential actions of a hormone-specific ␤1,4 GalNAc-transferase and a GalNAc-4-sulfotransferase are required for the synthesis of GalNAc-4-SO 4 on LH and other glycoproteins (13, (15) (16) (17) (18) (19) . Three key functions have been conserved throughout vertebrate evolution: 1) the peptide recognition determinant utilized by the GalNAc-transferase, 2) the GalNAc-transferase itself, and 3) the GalNAc-4-sulfotransferase. As a result, Nlinked structures terminating with ␤1,4-linked GalNAc-4-SO 4 occur on glycoprotein hormones from all vertebrate species (20) . GalNAc-transferase and GalNAc-4-sulfotransferase activities with the same properties as those expressed in the pituitary have been detected in other tissues and cells (21) . Furthermore, a number of other glycoproteins bearing N-and O-linked structures terminating with ␤1,4-linked GalNAc-4-SO 4 have been described (2, 5, (22) (23) (24) (25) (26) . Thus, oligosaccharides terminating with GalNAc-4-SO 4 
may fulfill a number of different roles in vivo.
Recently the HNK-1 sulfotransferase (HNK-1 ST), a glucuronyl-3-sulfotransferase that mediates synthesis of the HNK-1 epitope SO 4 -3-GlcA␤1,3Gal␤1,4GlcNAc (27) was cloned (28, 29) . The HNK-1 structure is found in the central and peripheral nervous systems on glycolipids and glycoproteins involved in neural recognition and synaptogenesis (Ref. 30 ; for reviews, see Refs. 31 and 32) . Expression of the HNK-1 structure is spatially and temporally regulated, suggesting an important role in axon outgrowth (33) . It is a predominant autoantigen in demyelinating diseases of the peripheral nervous system (34) . Recently this glycan has been recognized to be a crucial player in synaptic plasticity involving inhibitory interneurons in the hippocampus (35) . The sulfate group of the HNK-1 glycan is essential for its function (36, 37) .
Two proteins homologous to the HNK-1 ST have recently been identified as chondroitin GalNAc-4-sulfotransferases (38, 39) . We report here the identification of an additional GalNAc-4-sulfotransferase that is homolgous to HNK-1 ST and to the chondroitin 4-sulfotransferases. This GalNAc-4-sulfotransferase, highly expressed in the pituitary and other regions of the brain, is active with substrates terminating with GalNAc␤1,4GlcNAc␤-R, including the glycoprotein hormone LH. The GalNAc-4-sulfotransferase we describe accounts for the addition of sulfate to the N-linked structures found on LH and other glycoproteins that terminate with ␤1,4-linked GalNAc.
EXPERIMENTAL PROCEDURES

Materials-[␣-
32 P]dCTP and Megaprime labeling kit were purchased from Amersham Pharmacia Biotech. Bovine LH was provided by Dr. A. F. Parlow, NIDDK, National Institutes of Health National Hormone and Pituitary Program.
Molecular Cloning-The full-length GalNAc-4-ST1 cDNA was obtained by 5Ј-and 3Ј-rapid amplification of cDNAends (RACE) of the human fetal brain Marathon-Ready TM cDNA (CLONTECH) as template. The primers were based on the sequence of a GalNAc-4-ST1 exon identified in the genomic cosmid R28058 (GenBank TM accession number AC005615) using the 330 carboxyl-terminal amino acids of HNK-1 ST (see "Results"). The 3Ј sequence was amplified using the genespecific primer 5Ј-CCG TCT CAG CAC CTA CAC CAA GAT GCT C-3Ј and an anchor primer (AP1, CLONTECH) for the initial amplification followed by nested polymerase chain reaction with the AP2 anchor primer (CLONTECH) and a second GalNAc-4-ST1-specific primer 5Ј-GCA GCC CCT GCC TCA TCG ACT ACG ATT-3Ј. The 5Јsequence was obtained using the GalNAc-4-ST1 primer 5Ј-CCT TGG GCA CCT CGC AGT AGA GCA C-3Ј for initial amplification and the primer 5Ј-CGG TCC TCC ACG AAG ATA CGG GAC A-3Ј for nested polymerase chain reaction. The 5Ј sequence was also amplified from a SuperScript TM human fetal brain cDNA library (Life Technologies, Inc.) using the same gene-specific primers and the T7 primer as the anchor primer. Amplified products were subcloned into pCR-TOPO 2.1 (Invitrogen, NL) and sequenced.
In-silico Analysis of the Human GalNAc-4-ST1 Locus-A search of the non-redundant data base at the National Center for Biotechnology Information (National Institutes of Health) using BLASTN (40) with the GalNAc-4-ST1 sequence retrieved the genomic clones R28058, LLNLR-232F9, and F21136 (GenBank TM accession numbers AC005615, AC008994, AC007205). The preliminary sequence of R28058, F21136, and the overlapping genomic clone F2345 (LLNL-F_192H5) were obtained from the DOE Joint Genome Institute. A contig containing these sequences has been mapped to human chromosome 19q13.1 (41) . Comparison of the GalNAc-4-ST1 cDNA and the sequences of these genomic clones were used to define the organization of the GalNAc-4-ST1 gene.
Construction of pcDNA3.1-GalNAc-4-ST1(Met119) and pcDNA3.1-GalNAc-4-ST1-TurboPfu polymerase (Stratagene) and human genomic DNA were used to amplify the putative 921-bp open reading frame identified as an exon in the genomic cosmid clone R28058 using the 5Ј-specific primer 5Ј-ATA AGC TTG CCA CCA TGC CAG CTG CGG CGA CCA T-3Ј containing a HindIII recognition site, the consensus Kozak sequence GC-CACC and the start codon, and the 3Ј-specific primer 5Ј-CCG AAT TCT CAG TAC AGA TCT GCA AAG G-3Ј containing an EcoRI recognition site and the stop codon. The product was subcloned into pcDNA3.1 and designated pcDNA3.1-GalNAc-4-ST1(Met119). The complete open reading frame for GalNAc-4-ST1 was obtained by polymerase chain reaction using a SuperScript TM human fetal brain cDNA library as template, the 5Ј-specific primer 5Ј-ATA TAA GCT TGC CAC CAT GAC CCT GCG ACC TGG AAC AAT G-3Ј, and the 3Ј-specific primer described above. The 1275-bp product was subcloned into pcDNA3.1 and designated pcDNA3.1-GalNAc-4-ST1.
Northern Blot and Expression Array Analysis-Human multiple tissue Northern (MTN ® ) blots and human multiple tissue expression (MTE TM ) arrays were purchased from CLONTECH Laboratories Inc. They were hybridized with 5-15 ϫ 10 6 cpm of a GalNAc-4-ST1-specific ␣- chymostain) per 100-mm-diameter culture plate. The homogenate was mixed by rotation for 1 h and sedimented at 12,000 ϫ g for 20 min. The supernatant was designated as the cell extract. Cell culture medium was concentrated 20-fold by ultrafiltration after adding HEPES, pH 7.4, to a concentration of 20 mM and protease inhibitors (see above).
Sulfotransferase Assay-GalNAc-4-sulfotransferase reactions (50 l) were carried out at 28°C for up to15 h, and radiolabeled products were characterized as described previously on a CarboPak PA1 column (Dionex) (42 (42) .
Chondroitin 4-sulfotransferase was assayed using chondroitin (Seikagaku Corp.) as described (43) and HNK-1 sulfotransferase activity was assayed using the acceptor GlcA␤1,3Gal␤1,4GlcNAc␤1,3Gal␤1, 4Glc␤1,C 2 H 4 NHCOCF 3 as described previously (28), except that the reactions were carried out for 15 h.
GalNAc-4-Sulfotransferase Product Characterization-Glycoproteins were tested as substrates for GalNAc-4-ST1 using the conditions described above for oligosaccharide acceptors. Each 50-l reaction contained 3 g of purified bovine parotid carbonic anhydrase VI (25) , bovine LH, enzymatically desulfated bovine LH (10, 44), or asialo human chorionic gonadotrophin. After 16 h at 28°C, duplicate reactions were either stopped by the addition of an equal volume of sample buffer (10% glycerol, 5% 2-mercaptoethanol, 2% SDS, 0.003% bromphenol blue, and 62.5 mM Tris, pH 6.8) or were digested with 34 microunits of peptide:N-glycosidase as described (10) before the addition of sample buffer. The [
35 S]SO 4 -labeled proteins were separated by SDS-polyacrylamide gel electrophoresis (12% acrylamide) and detected by autoradiography.
RESULTS
Identification of a Novel Human cDNA Related to HNK-1 ST-
The carboxyl-terminal 330 amino acids of rat HNK-1 ST sequence (GenBank TM accession number AF022729) (28) were used to screen the non-redundant data base at the NCBI for additional potential sulfotransferases using TBLASTN (40) . A genomic cosmid clone, R28058 (GenBank TM accession number AC005615), that maps to human chromosome 19q13.1 (41) was identified. A potential 1107-bp exon with a high degree of similarity to HNK-1 ST was identified between position 16995 and 18101 using FGENESH (45) . Based on this sequence information, a 1940-bp cDNA was amplified from human fetal brain cDNA libraries using rapid amplification of cDNA ends. The fourth in-frame ATG in the cDNA sequence is preceded by three in-frame stop codons, indicating it is the start codon (Fig.  1A) . The 1275-bp open reading frame predicts a protein of 424-amino acid residues ( Fig. 1A ) with a molecular mass of 48.8 kDa and 4 potential N-linked glycosylation sites. A hydrophobic, membrane-spanning sequence near the amino terminus is predicted by a hidden Markov model-based algorithm indicating a type II transmembrane glycoprotein (Fig. 1B) . Based on the specificity described below, we have designated this protein as GalNAc-4-ST1.
Alignment of the protein sequence of GalNAc-4-ST1 with HNK-1 ST along with C4ST-1 and C4ST-2, which are also homologous to HNK-1 ST (38) , is shown in Fig. 2 . GalNAc-4-ST1 displays 23% identity over its entire sequence to human and rat HNK-1 ST, 28% identity to C4ST-1, and 26% identity to C4ST-2. Regions identified as putative 5Ј-phosphosulfonate and 3Ј-phosphate binding sites based on the crystal structures of estrogen sulfotransferase (46, 47) and heparan deacetylase N-sulfotransferase (48) have the highest percentage of identical amino acids. Three additional regions, each of which have a high percentage of amino acids that are identical to those in the corresponding regions of C4ST-1, C4ST-2, and HNK-1 ST, are located carboxyl-terminal to the 3Ј-phosphate binding site and are identified as III, IV, and V in Fig. 2 . Three invariant Cys residues, two in region IV (Fig. 2 , residues 366 and 369) and one immediately preceding the 5Ј-phosphosulfonate binding site (Fig. 2, residue 198) , are present in all four sulfotransferases. Notably, the Cys located within the 5Ј-phosphosulfonate binding site of GalNAc-4-ST1, C4ST-1, and C4ST-2 (Fig. 2 , residue 190) is replaced with an Asn in HNK-1 ST. The extensive conservation of amino acid sequences between GalNAc-4-ST1 and HNK-1 ST, C4ST-1, and C4ST-2 suggested that it would transfer sulfate to either GalNAc or GlcA.
GalNAc-4-ST1 Transfers Sulfate to Terminal ␤1,4-linked
GalNAc-After transfection of CHO/Tag cells with pcDNA3.1-GalNAc-4-ST1, cell extracts were prepared and tested for transfer of sulfate to the saccharide acceptors shown in Table I . The oligosaccharide acceptors were tested at 20 and 100 M, concentrations that are, respectively, equal to and 6.7-fold greater than the K m of 15 M that we previously reported for GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO with the GalNAc-4-sulfotransferase found in the pituitary gland (42, 49). Like
The sulfated product was characterized as described previously (42) to establish the location of the sulfate. The [
35 S]SO 4 -labeled GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO co-migrated with authentic SO 4 -4-GalNAc␤1,4GlcNAc␤1,2Man␣-MCO when analyzed by high performance liquid chromatography (Fig. 3A) . After mild acid hydrolysis, GalNAc-4-SO 4 , unhydrolyzed SO 4 -4-GalNAc␤1,4GlcNAc␤1,2Man␣-MCO, and free SO 4 were the only products obtained (Fig. 3B) . Thus, GalNAc-4-ST1 transfers sulfate exclusively to the C4 hydroxyl of the terminal GalNAc in GalNAc␤1,4GlcNAc␤1,2Man␣-MCO.
We also examined GalNAc-4-ST1 for its ability to transfer sulfate to glycoproteins, such as the glycoprotein hormones LH and thyrotropin and carbonic anhydrase VI, which bear Nlinked oligosaccharides terminating with the sequence SO 4 -4-GalNAc␤1,4 GlcNAc␤1,2Man␣. GalNAc-4-ST1 efficiently transfers sulfate to both bovine parotid carbonic anhydrase VI, which bears terminal GalNAc that is not sulfated (25) , and to bovine LH (Fig. 4) . Digestion of LH with GalNAc-4-sulfatase (10, 44) removes pre-existing terminal sulfate residues from the N-linked oligosaccharides and results in a significant increase in the amount of sulfate transferred to the same amount of LH acceptor (Fig. 4) . The sulfate label is released from the glycoprotein acceptors by digestion with peptide:N-glycosidase, demonstrating that it is located on N-linked oligosaccharides. Sulfate was not transferred to glycoproteins bearing oligosaccharides with terminal ␤1,4-linked Gal, such as asialo-human chorionic gonadotrophin (Fig. 4) . Thus, GalNAc-4-ST1 specifically modifies oligosaccharides on glycoproteins bearing terminal ␤1,4-linked GalNAc by the addition of sulfate.
Since GalNAc-4-ST1 is homologous to HNK-1 ST, C4ST-1, and C4ST-2, we examined GalNAc-4-ST1, HNK-1 ST, and C4ST-1 for their ability to transfer sulfate to GalNAc␤1, 4GlcNAc␤1,2Man␣-MCO, the HNK-1 precursor GlcA␤1,3Gal ␤1,4GlcNAc␤1,3Gal␤1,4Glc␤-R, and chondroitin. HNK-1 ST, which transferred 1.96 pmol/h/100-mm plate to 40 M GlcA␤1,3Gal␤1,4GlcNAc␤1,3Gal␤14Glc␤-R, did not show any activity against either GalNAc␤1,4GlcNAc␤1,2Man␣-MCO or chondroitin (Ͻ0.019 pmol/h/100-mm plate). Furthermore, HNK-1 ST activity was confined to the cell extract. C4ST-1, like HNK-1 ST, was not active with GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO even though it demonstrated good activity with chondroitin (Fig. 5F ).
Two forms of GalNAc-4-ST1 were characterized for sulfotransferase activity. pcDNA3.1-GalNAc-4-ST1 consists of the full-length sequence shown in Fig. 1A . pcDNA3.1-GalNAc-4-ST1(Met119) con- 
TABLE I
The GalNAc-4-ST1 requires terminal ␤1,4-linked GalNAc CHO/Tag cells were transfected with pcDNA3.1-GalNAc-4-ST1 or pcDNA3.1-GalNAc-4-ST1(Met119). CHO/Tag cells expressing GalNAc-4-ST1 were solubilized in 200 l of 1% Triton X-100, and 5 l of cell extract was utilized for a 2.5-h assay. The medium from CHO/Tag cells expressing GalNAc-4-ST1(Met119) was collected and concentrated to 2 ml by ultafiltration, and 10 l was utilized for an 16- ferase activity toward GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO almost exclusively in the medium (Fig. 5, D versus E) . Thus, initiation at the AUG codon encoding Met-119 of GalNAc-4-ST1 allows the synthesis of a protein that enters the endoplasmic reticulum and is ultimately secreted in an active form. Notably, GalNAc-4-ST1(Met119) transfers sulfate to chondroitin at the same rate as to GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO (Fig. 5E ). In contrast, C4ST-1 in the cell extract of CHO/Tag cells transfected with pcDNA3.1-C4ST-1 is highly active with chondroitin but shows no activity with GalNAc␤1,4GlcNAc␤1,2Man␣-MCO (Fig. 5F ). Nonetheless, GalNAc-4-ST1(Met119) displays the same requirement for terminal ␤1,4-linked GalNAc and the same preference for GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO over GalNAc␤1,4 GlcNAc␤-MCO as the full-length GalNAc-4-ST1 (Table I) . Transfection of CHO/Tag cells with a cDNA encoding the fulllength sequence of GalNAc-4-ST1 also resulted in the appearance of sulfotransferase activity toward GalNAc␤1,4GlcNAc␤1,2Man␣-MCO in both the cell extract and the medium (Fig. 5, B versus C) . Despite the presence of the transmembrane domain, 97% of the activity is released into the medium, whereas only 3% is retained by the cells. This is marked contrast to HNK-1 ST, where all of the activity was found in the cell extract after transfection with pcDNA3.1-HNK-1 ST (not shown). The GalNAc-4-ST1 released into the medium, like GalNAc-4-ST1(Met119), is able to transfer sulfate to chondroitin (Fig. 5C) ; however, GalNAc-4-ST1 in the medium transfers sulfate to GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO at a 12-fold higher rate than to chondroitin. In addition, the amount of sulfotransferase activity for GalNAc␤1,4GlcNAc␤1,2Man␣-MCO is 21-fold greater in the medium for cells expressing full-length GalNAc-4-ST1 than the truncated GalNAc-4-ST1(Met119) (Fig. 5, 
C versus E).
The GalNAc-4-ST1 present in the cell extract transfers sulfate to GalNAc␤1,4 GlcNAc␤1,2Man␣-MCO at a rate that is Ͼ170-fold higher than to chondroitin (Fig. 5B) . Since GalNAc-4-ST1 has a putative transmembrane domain at its amino terminus, release into the medium likely reflects proteolytic cleavage, as has been seen for other glycosyltransferases (50) . As a result, the GalNAc-4-ST1 found in the medium, like GalNAc-4-ST1(Met119), is also truncated. Taken together, the properties of the three different forms of GalNAc-4-ST1 indicate that the first 118 amino acids located at the amino terminus determine the specificity for GalNAc␤1,4GlcNAc␤1,2Man␣ sequence at the termini of N-linked oligosaccharides on glycoproteins such as LH. The 25-fold greater activity obtained from cells expressing GalNAc-4-ST1 than GalNAc-4-ST1(Met119) also suggests that the full-length form of GalNAc-4-ST1, and its proteolytic cleavage product may be significantly more active than the truncated form.
Expression Pattern of GalNAc-4-ST1-The expression pattern of GalNAc-4-ST1 in human tissues was examined using Array and Northern blot analyses (Figs. 6 and 7, respectively). As shown in Fig. 6 , GalNAc-4-ST1 message was most highly represented in the central nervous system in pituitary gland (D3), cerebellum (A2, B2), pons (H1), medulla oblongata (G2), thalamus (C3), and spinal cord (E3). Fetal brain also showed strong expression of the GalNAc-4-ST1 message (A11). Other regions of the central nervous system also displayed modest, but detectable, levels of message. Outside the central nervous system, lymph nodes (F7) displayed a relatively strong signal, whereas lung (A8), spleen (C7), adrenal gland (C9), prostate (E8), testis (F8), atrium (C4, D4), mammary gland (F9), and trachea (H7) displayed weak signals. A single 2.4-kilobase transcript was highly prominent by Northern blot analysis in the brain (Fig. 7) . The same 2.4-kilobase transcript was present but at significantly lower levels in liver, heart, and pancreas (Fig. 7) . Although present by visual examination in skeletal muscle, the 2.4-kilobase transcript cannot be seen in the autoradiograph shown in Fig. 7 .
Genomic Organization and Chromosome Localization-The GalNAc-4-ST1 gene is located on human chromosome 19q13.1. The gene consists of at least one untranslated exon of unknown size and three translated exons as depicted in Fig. 8 . The gene covers roughly 88 kilobases of genomic DNA. Notably it is the sequence of the first 118 amino acids largely encoded in exons   FIG. 4. GalNAc-4-ST1 transfers sulfate to N-linked oligosaccharides terminating with the sequence GalNAc␤1,4GlcNAc␤1,2Man␣  on glycoproteins. CHO/Tag cells were transfected with pcDNA3.1-GalNAc-4-ST1, and a cell extract was prepared. GalNAc-4-ST1, 5 l, was incubated with 3 g each of bovine carbonic anhydrase VI (CA-VI) (from parotid gland), LH, or desulfated LH (treated with GalNAc-4-sulfatase) and [ 2 and 3 that determine the specificity of GalNAc-4-ST1 for GalNAc␤1,4GlcNAc␤1,2Man␣-MCO over chondroitin.
DISCUSSION
Cloning the cDNA for the GalNAc-4-sulfotransferase responsible for sulfate addition to the N-linked oligosaccharides on LH represents an important advance in our understanding of the biologic significance of this highly conserved element of glycoprotein hormone biology. The glycoprotein hormones LH and thyrotropin were the first mammalian glycoproteins demonstrated to bear N-linked oligosaccharides terminating with the unique sequence SO 4 -4-GalNAc␤1,4GlcNAc␤1,2Man␣ (51, 52) . This sulfated structure was subsequently described on a limited number of other glycoproteins that are synthesized in the pituitary and in other tissues (2, 5, (22) (23) (24) (25) (26) (53) (54) (55) . These structures play a critical role in the biology of LH because they are recognized by a specific receptor, the Man/GalNAc-4-SO 4 receptor located in hepatic endothelial cells (11) that regulates the circulatory half-life of LH (10) . In conjunction with the stimulated release from dense core storage granules in gonadotrophs, the short half-life accounts for the episodic rise and fall in circulating LH levels. This is essential for activation of the LH receptor because of rapid down-regulation of the activated receptor by ␤-arrestin (14) . An indication of the importance of these structures is their presence on glycoprotein hormones of all vertebrate species from fish to man (20) . For this to occur, key features of the GalNAc-4-sulfotransferase as well as the hormone-specific GalNAc-transferase and the recognition determinant utilized by the GalNAc-transferase all had to be conserved throughout vertebrate evolution.
Even though GalNAc-4-ST1, C4ST-1, C4ST-2, and HNK-1 ST are structurally related, there are numerous differences in their amino acid sequences. GalNAc-4-ST1 has a higher percentage of identical residues to C4ST-1 (28% identical) and C4ST-2 (26% identical) than to HNK-1 ST (23% identical) based on the alignment shown in Fig. 2 . Thus, GalNAc-4-ST1 is structurally more closely related to C4ST-1 and C4ST-2 than to HNK-1 ST. These structural relationships are reflected in the respective functional activities of these sulfotransferases. GalNAc-4-ST1, C4ST-1, and C4ST-1 transfer sulfate to the 4 position of ␤1,4-linked GalNAc but are not able to transfer sulfate to ␤1,3-linked GlcA. Conversely, HNK-1 ST transfers sulfate to the 3 position of ␤1,3-linked GlcA but not to ␤1,4-linked GalNAc. The structural relationship of GalNAc-4-ST1, C4ST-1, and C4ST-2 to HNK-1 ST is surprising in light of the marked differences in their specificities. Understanding the structural basis for these differences will clearly be of interest.
GalNAc-4-ST1 can account for the addition of sulfate to the terminal GalNAc on glycoprotein hormone N-linked oligosaccharides. Even though GalNAc-4-ST1 is homologous to C4ST-1, GalNAc-4-ST1 in cell extracts shows exclusive specificity for GalNAc␤1,4GlcNAc␤1,2Man␣-MCO. In contrast, truncated forms of GalNAc-4-ST1 transfer sulfate to chondroitin as well as to GalNAc␤1,4GlcNAc␤1,2Man␣-MCO. This indicates that the amino-terminal 118 amino acids dictate the specificity of GalNAc-4-ST1 for GalNAc␤1,4GlcNAc␤1,2Man␣-MCO. We are currently examining the sulfated chondroitin products obtained with truncated forms of GalNAc-4-ST1 to determine if sulfate is transferred to terminal or internal GalNAc residues or to both. Transfer to GalNAc␤1,4GlcA␤, located at the nonreducing terminus of chondroitin, would suggest that the first 118 amino acids allow GalNAc-4-ST1 to discriminate between an underlying GlcNAc and GlcA residue. Transfer to internal GalNAc residues in chondroitin would suggest the first 118 amino acids prevent recognition of GalNAc that is not located at a non-reducing terminus.
GalNAc-4-sulfotransferase activity has been detected in the pituitaries of all vertebrate species examined to date (20) , as would be required by the presence of N-linked oligosaccharides terminating with the sequence SO 4 -4-GalNAc␤1,4GlcNAc␤1,2Man␣ on their glycoprotein hormones. We have identified a homologous sequence that is 78% identical to human GalNAc-4-ST1 over a 198-amino acid sequence in a 592 bp cDNA obtained from a Xenopus egg library (GenBank TM accession number AW641290), suggesting that a transferase with the same activity and specificity as human GalNAc-4-ST1 is indeed expressed by amphibians. This would support our hypothesis that the sulfated oligosaccharides on Xenopus glycoprotein hormones also serve to regulate their circulatory halflife. If this is the case, the hormone-specific ␤1,4-GalNAc-transferase and the GalNAc-4-SO 4 -specific receptor should also be present in Xenopus.
GalNAc-4-ST1 is expressed in multiple regions of the brain. The highest level of expression is in the pituitary, where at least three glycoproteins are known to bear oligosaccharides with terminal ␤1,4-linked GalNAc-4-SO 4 : LH, thyrotropin, and pro-opiomelanocortin. Since these glycoproteins are major synthetic products of gonadotroph, thyrotroph, and corticotroph cells, the three major cell types in the anterior pituitary, high levels of GalNAc-4-ST1 are expected in the pituitary. The amount of LH synthesized changes in gonadotrophs in response to estrogen during the ovulatory cycle in mammals. The levels of hormone-specific GalNAc-transferase changes in parallel to those of LH (56) . Since the terminal GalNAc on the N-linked oligosaccharides of LH and other glycoproteins can also be modified with terminal ␣2,6-linked sialic acid (3, 13, 26, (57) (58) (59) (60) (61) (62) , the levels of GalNAc-4-sulfotransferase as well as ␣2,6-sialyltransferase may determine which structure is ultimately present on LH and other glycoproteins bearing such oligosaccharides. This would have a profound impact on both the rate and the site of clearance for LH. As a result, understanding the regulation of GalNAc-4-ST1 expression within the three types of anterior pituitary cells will be of considerable importance.
We have previously shown that expression of the hormonespecific ␤1,4-GalNAc-transferase is highly regulated in vivo. Expression of the ␤1,4-GalNAc-transferase is hormonally regulated in the pituitary (56) and developmentally regulated in the rat placenta (57) . In each instance that high levels of ␤1,4-GalNAc-transferase have been detected, specific glycoproteins bearing a recognition determinant and ␤1,4-linked GalNAc have been identified. Co-ordinate expression of the protein-specific ␤1,4-GalNAc-transferase and GalNAc-4-ST1 will result in the specific modification of those glycoproteins that bear a peptide sequence recognized by the ␤1,4-GalNAc-transferase. We have previously determined that glycoprotein hormone-specific ␤1,4-GalNAc-transferase activity and GalNAc-4-sulfotransferase activity are present in regions of the brain other than the pituitary (21) . The presence of GalNAc-4-ST1 message in both fetal brain and in various regions of the central nervous system suggests that N-linked structures terminating with ␤1,4-linked GalNAc-4-SO 4 will be present on specific glycoproteins. Like HNK-1, structures terminating with ␤1,4-linked GalNAc-4-SO 4 may play a role in development of the nervous system and processes requiring specific recognition in the adult brain. The expression of GalNAc-4-ST1 in a number of tissues as well as in fetal brain strongly supports our proposal that the tightly regulated synthesis of structures with terminal ␤1,4-linked GalNAc-4-SO 4 in a number of different settings will be utilized for diverse biologic functions requiring recognition.
